{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:36:37Z","timestamp":1787495797328,"version":"build-2736575974"},"reference-count":54,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"\n Background<\/jats:title>\n Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma (NHL) subtype in adults. Dysregulation of replication factor C subunit 3 (RFC3) gene expression were associated with disease progression and poor prognosis in various cancer types. However, its significance in DLBCL remains largely unexplored. This study aimed to characterize RFC3 expression patterns, clinical relevance, functional mechanisms, and potential therapeutic implications in DLBCL.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Multi-omics analyses were performed using data extracted from the Gene Expression Omnibus (GEO) project (\n GSE181063<\/jats:uri>\n ,\n GSE10846<\/jats:uri>\n ,\n GSE32918<\/jats:uri>\n ,\n GSE31312<\/jats:uri>\n ,\n GSE32018<\/jats:uri>\n , and\n GSE12453<\/jats:uri>\n ) and The Cancer Genome Atlas (TCGA). RFC3 expression was validated\n via<\/jats:italic>\n immunohistochemistry (IHC) in DLBCL samples. Survival analysis was conducted using the Kaplan\u2013Meier method. The chi-square test was used to assess the association between RFC3 expression and clinical characteristics of DLBCL. Gene Set Enrichment Analysis (GSEA) was employed to identify tumor signaling pathways associated with RFC3. Immune infiltration was evaluated using the Immuno-Oncology Biological Research (IOBR) package. Drug sensitivity analysis was performed using the oncoPredict package, and immunotherapy response was assessed via the IMvigor210 dataset. Pan-cancer analysis was conducted using the easyTCGA and TCGAplot packages available on the R software.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n RFC3 expression was significantly upregulated in DLBCL. High RFC3 expression was closely associated with poor prognosis, adverse clinical features, and adverse tumor microenvironment characteristics in DLBCL patients. Furthermore, multiple tumor proliferation and cancer-related signaling pathways were significantly enriched in the high RFC3 expression group. The pan-cancer analysis also revealed elevated RFC3 expression across several tumor types. Elevated RFC3 expression was strongly correlated with worse tumor prognosis.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n RFC3 may serve as a novel prognostic biomarker and a potential therapeutic target for DLBCL. Further investigations into the mechanisms underlying RFC3 dysregulation may provide important insights for future diagnostic and therapeutic strategies.<\/jats:p>\n <\/jats:sec>","DOI":"10.7717\/peerj.20001","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:35:06Z","timestamp":1758011706000},"page":"e20001","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic significance and pathogenesis of RFC3 gene expression in diffuse large B-cell lymphoma"],"prefix":"10.7717","volume":"13","author":[{"given":"Zuguo","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuiyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlan","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"8","key":"10.7717\/peerj.20001\/ref-1","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3390\/biomedicines12081766","article-title":"Genetic and epigenetic biomarkers associated with early relapse in pediatric acute lymphoblastic Leukemia: a focused bioinformatics study on DNA-repair genes","volume":"12","author":"Albaqami","year":"2024","journal-title":"Biomedicines"},{"key":"10.7717\/peerj.20001\/ref-2","doi-asserted-by":"publisher","first-page":"6961","DOI":"10.1007\/s00784-023-05316-4","article-title":"RFC3 serves as a novel prognostic biomarker and target for head and neck squamous cell carcinoma","volume":"27","author":"Avs","year":"2023","journal-title":"Clinical Oral Investigations"},{"key":"10.7717\/peerj.20001\/ref-3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.7717\/peerj.20001\/ref-4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-015-0474-2","article-title":"Novel drug targets for personalized precision medicine in relapsed\/refractory diffuse large B-cell lymphoma: a comprehensive review","volume":"14","author":"Camicia","year":"2015","journal-title":"Molecular Cancer"},{"key":"10.7717\/peerj.20001\/ref-5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3324\/haematol.2010.037408","article-title":"High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy","volume":"96","author":"Cardesa-Salzmann","year":"2011","journal-title":"Haematologica"},{"key":"10.7717\/peerj.20001\/ref-6","doi-asserted-by":"publisher","first-page":"7591","DOI":"10.1093\/nar\/gku451","article-title":"SPIB and BATF provide alternate determinants of IRF4 occupancy in diffuse large B-cell lymphoma linked to disease heterogeneity","volume":"42","author":"Care","year":"2014","journal-title":"Nucleic Acids Research"},{"key":"10.7717\/peerj.20001\/ref-7","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/PGPM.S309846","article-title":"Ferroptosis-related gene signature: a new method for personalized risk assessment in patients with diffuse large B-cell lymphoma","volume":"14","author":"Chen","year":"2021","journal-title":"Pharmacogenomics and Personalized Medicine"},{"key":"10.7717\/peerj.20001\/ref-8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.62347\/ZIEG9007","article-title":"Correlation of LOXL2 expression in non-small cell lung cancer with immunotherapy","volume":"17","author":"Chen","year":"2024","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.7717\/peerj.20001\/ref-9","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/annonc\/mdz386","article-title":"Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue","volume":"30","author":"Ciavarella","year":"2019","journal-title":"Annals of Oncology"},{"key":"10.7717\/peerj.20001\/ref-10","doi-asserted-by":"publisher","first-page":"8586354","DOI":"10.1155\/2019\/8586354","article-title":"Tumor microenvironment in diffuse large B-cell lymphoma: role and prognosis","volume":"2019","author":"Cioroianu","year":"2019","journal-title":"Analytical Cellular Pathology"},{"key":"10.7717\/peerj.20001\/ref-11","doi-asserted-by":"publisher","first-page":"1070777","DOI":"10.3389\/fcell.2023.1070777","article-title":"A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment","volume":"11","author":"Cui","year":"2023","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.7717\/peerj.20001\/ref-12","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1128\/MCB.15.9.4661","article-title":"Characterization of the five replication factor C genes of Saccharomyces cerevisiae","volume":"15","author":"Cullmann","year":"1995","journal-title":"Molecular and Cellular Biology"},{"issue":"8","key":"10.7717\/peerj.20001\/ref-13","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/cancers14081857","article-title":"Biological and clinical implications of gene-expression profiling in diffuse large B-cell lymphoma: a proposal for a targeted BLYM-777 consortium panel as part of a multilayered analytical approach","volume":"14","author":"De\u00a0Groot","year":"2022","journal-title":"Cancers"},{"key":"10.7717\/peerj.20001\/ref-14","doi-asserted-by":"publisher","first-page":"5517","DOI":"10.1182\/blood-2011-03-344374","article-title":"PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma","volume":"118","author":"Gomez-Abad","year":"2011","journal-title":"Blood"},{"key":"10.7717\/peerj.20001\/ref-15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11684-022-0938-x","article-title":"Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma in vitro and in vivo","volume":"17","author":"Guan","year":"2023","journal-title":"Frontiers in Medicine"},{"key":"10.7717\/peerj.20001\/ref-16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.7717\/peerj.20001\/ref-17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tranon.2016.10.004","article-title":"Up-regulation of RFC3 promotes triple negative breast cancer metastasis and is associated with poor prognosis via EMT","volume":"10","author":"He","year":"2017","journal-title":"Translational Oncology"},{"key":"10.7717\/peerj.20001\/ref-18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41065-021-00179-9","article-title":"Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma","volume":"158","author":"Ji","year":"2021","journal-title":"Hereditas"},{"key":"10.7717\/peerj.20001\/ref-19","article-title":"survminer: drawing survival curves using \u2018ggplot2\u2019","author":"Kassambara","year":"2021"},{"key":"10.7717\/peerj.20001\/ref-20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.21873\/cgp.20493","article-title":"RFC3 knockdown decreases cervical cancer cell proliferation, migration and invasion","volume":"22","author":"Koh","year":"2025","journal-title":"Cancer Genomics Proteomics"},{"key":"10.7717\/peerj.20001\/ref-21","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1038\/bcj.2017.37","article-title":"Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma","volume":"7","author":"Kusano","year":"2017","journal-title":"Blood Cancer Journal"},{"key":"10.7717\/peerj.20001\/ref-22","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","article-title":"Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a haematological malignancy research network report","volume":"135","author":"Lacy","year":"2020","journal-title":"Blood"},{"key":"10.7717\/peerj.20001\/ref-23","article-title":"Make TCGA download and prepare easy","author":"Li","year":"2024"},{"key":"10.7717\/peerj.20001\/ref-24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","article-title":"TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data","volume":"24","author":"Liao","year":"2023","journal-title":"BMC Bioinformatics"},{"key":"10.7717\/peerj.20001\/ref-25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Systems"},{"key":"10.7717\/peerj.20001\/ref-26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/CJI.0000000000000497","article-title":"A new method for constructing macrophage-associated predictors of treatment efficacy based on single-cell sequencing analysis","volume":"47","author":"Lin","year":"2024","journal-title":"Journal of Immunotherapy"},{"key":"10.7717\/peerj.20001\/ref-27","doi-asserted-by":"publisher","first-page":"1191033","DOI":"10.3389\/fimmu.2023.1191033","article-title":"Prognostic impact of peripheral natural killer cells in primary central nervous system lymphoma","volume":"14","author":"Lin","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"6","key":"10.7717\/peerj.20001\/ref-28","doi-asserted-by":"publisher","first-page":"bbab260","DOI":"10.1093\/bib\/bbab260","article-title":"oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data","volume":"22","author":"Maeser","year":"2021","journal-title":"Briefings in Bioinformatics"},{"key":"10.7717\/peerj.20001\/ref-29","article-title":"IMvigor210CoreBiologies: data processing and analysis code for the manuscript Mariathasan et al. TGF-b attenuates tumor response to PD-L1 blockade by contributing to exclusion of T cells","author":"Nickles","year":"2019"},{"key":"10.7717\/peerj.20001\/ref-30","first-page":"3070","article-title":"G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer","volume":"11","author":"Oshi","year":"2021","journal-title":"American Journal of Cancer Research"},{"issue":"7","key":"10.7717\/peerj.20001\/ref-31","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/cells9071643","article-title":"The E2F pathway score as a predictive biomarker of response to neoadjuvant therapy in ER+\/HER2- breast cancer","volume":"9","author":"Oshi","year":"2020","journal-title":"Cell"},{"key":"10.7717\/peerj.20001\/ref-32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/bjh.15619","article-title":"Cell-of-origin in diffuse large B-cell lymphoma: findings from the UK\u2019s population-based haematological malignancy research network","volume":"185","author":"Painter","year":"2019","journal-title":"British Journal of Haematology"},{"issue":"61","key":"10.7717\/peerj.20001\/ref-33","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.21105\/joss.03167","article-title":"Visualizations with statistical details: the \u2018ggstatsplot\u2019 approach","volume":"6","author":"Patil","year":"2021","journal-title":"Journal of Open Source Software"},{"key":"10.7717\/peerj.20001\/ref-34","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/S0140-6736(19)33008-9","article-title":"Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial","volume":"394","author":"Poeschel","year":"2019","journal-title":"Lancet"},{"key":"10.7717\/peerj.20001\/ref-35","doi-asserted-by":"publisher","first-page":"3168172","DOI":"10.1155\/2022\/3168172","article-title":"Defining diffuse large B-cell lymphoma immunotypes by CD8+ T cells and natural killer cells","volume":"2022","author":"Qi","year":"2022","journal-title":"Journal of Oncology"},{"key":"10.7717\/peerj.20001\/ref-36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.7717\/peerj.20001\/ref-37","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.2019002729","article-title":"International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI","volume":"135","author":"Ruppert","year":"2020","journal-title":"Blood"},{"issue":"21","key":"10.7717\/peerj.20001\/ref-38","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/ijms21218127","article-title":"MYC targets scores are associated with cancer aggressiveness and poor survival in ER-positive primary and metastatic breast cancer","volume":"21","author":"Schulze","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.20001\/ref-39","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.18.01314","article-title":"Molecular high-grade B-Cell lymphoma: defining a poor-risk group that requires different approaches to therapy","volume":"37","author":"Sha","year":"2019","journal-title":"Journal of Clinical Oncology"},{"key":"10.7717\/peerj.20001\/ref-40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21147\/j.issn.1000-9604.2019.01.10","article-title":"Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: analysis of 1,085 WHO classified cases in a single institution in China","volume":"31","author":"Shi","year":"2019","journal-title":"Chinese Journal of Cancer Research"},{"key":"10.7717\/peerj.20001\/ref-41","doi-asserted-by":"publisher","first-page":"1113455","DOI":"10.3389\/fimmu.2023.1113455","article-title":"Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma","volume":"14","author":"Sun","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.7717\/peerj.20001\/ref-42","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.7717\/peerj.20001\/ref-43","article-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2022"},{"key":"10.7717\/peerj.20001\/ref-44","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1111\/febs.13668","article-title":"Immune checkpoint blockade in lymphoid malignancies","volume":"283","author":"Thanarajasingam","year":"2016","journal-title":"The FEBS Journal"},{"key":"10.7717\/peerj.20001\/ref-45","article-title":"A package for survival analysis in R","author":"Therneau","year":"2023"},{"key":"10.7717\/peerj.20001\/ref-46","doi-asserted-by":"publisher","first-page":"9071","DOI":"10.1074\/jbc.M709835200","article-title":"DNA damage-induced ubiquitylation of RFC2 subunit of replication factor C complex","volume":"283","author":"Tomida","year":"2008","journal-title":"Journal of Biological Chemistry"},{"key":"10.7717\/peerj.20001\/ref-47","article-title":"gmodels: various R programming tools for model fitting","author":"Warnes","year":"2022"},{"key":"10.7717\/peerj.20001\/ref-48","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1172\/JCI95993","article-title":"Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells","volume":"128","author":"Weniger","year":"2018","journal-title":"Journal of Clinical Investigation"},{"key":"10.7717\/peerj.20001\/ref-49","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1182\/bloodadvances.2020001949","article-title":"A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL","volume":"4","author":"Xu-Monette","year":"2020","journal-title":"Blood Advances"},{"key":"10.7717\/peerj.20001\/ref-50","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/mc.23523","article-title":"RFC5, regulated by circ_0038985\/miR-3614-5p, functions as an oncogene in the progression of colorectal cancer","volume":"62","author":"Yao","year":"2023","journal-title":"Molecular Carcinogenesis"},{"key":"10.7717\/peerj.20001\/ref-51","doi-asserted-by":"publisher","first-page":"110713","DOI":"10.1016\/j.celrep.2022.110713","article-title":"A single-cell atlas of diffuse large B cell lymphoma","volume":"39","author":"Ye","year":"2022","journal-title":"Cell Reports"},{"key":"10.7717\/peerj.20001\/ref-52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.7717\/peerj.20001\/ref-53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3892\/etm.2024.12510","article-title":"RFC3 drives the proliferation, migration, invasion and angiogenesis of colorectal cancer cells by binding KIF14","volume":"27","author":"Yu","year":"2024","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.7717\/peerj.20001\/ref-54","doi-asserted-by":"publisher","first-page":"100910","DOI":"10.1016\/j.crmeth.2024.100910","article-title":"Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR 2.0","volume":"4","author":"Zeng","year":"2024","journal-title":"Cell Reports Methods"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/20001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20001.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20001.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:35:10Z","timestamp":1758011710000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/20001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":54,"alternative-id":["10.7717\/peerj.20001"],"URL":"https:\/\/doi.org\/10.7717\/peerj.20001","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"article-number":"e20001"}}